These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25274124)

  • 21. Health care systems in transition: People's Republic of China. Part I: An overview of China's health care system.
    Hillier S; Shen J
    J Public Health Med; 1996 Sep; 18(3):258-65. PubMed ID: 8887833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development and reform of public health in China from 1949 to 2019.
    Wang L; Wang Z; Ma Q; Fang G; Yang J
    Global Health; 2019 Jul; 15(1):45. PubMed ID: 31266514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Policy experimentation and innovation as a response to complexity in China's management of health reforms.
    Husain L
    Global Health; 2017 Aug; 13(1):54. PubMed ID: 28774319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chinese-style decentralization and health system reform.
    Hipgrave D; Guo S; Mu Y; Guo Y; Yan F; Scherpbier R; Brixi H
    PLoS Med; 2012; 9(11):e1001337. PubMed ID: 23139644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. China's health care sector in transition: resources, demand and reforms.
    Wu Y
    Health Policy; 1997 Feb; 39(2):137-52. PubMed ID: 10165043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Building institutions for an effective health system: lessons from China's experience with rural health reform.
    Bloom G
    Soc Sci Med; 2011 Apr; 72(8):1302-9. PubMed ID: 21439699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary health care in China: is China's health reform reform for the whole nation?
    Cheng JM; Yuan YX; Lu W; Yang L
    Prim Health Care Res Dev; 2017 Jul; 18(4):398-403. PubMed ID: 28290254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Financing and organization of China's health care.
    Hu TW
    Bull World Health Organ; 2004 Jul; 82(7):480. PubMed ID: 15500280
    [No Abstract]   [Full Text] [Related]  

  • 30. From a national, centrally planned health system to a system based on the market: lessons from China.
    Ma J; Lu M; Quan H
    Health Aff (Millwood); 2008; 27(4):937-48. PubMed ID: 18607026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New evidence on financing equity in China's health care reform--a case study on Gansu province, China.
    Chen M; Chen W; Zhao Y
    BMC Health Serv Res; 2012 Dec; 12():466. PubMed ID: 23244513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards an equitable healthcare in China: evaluating the productive efficiency of community health centers in Jiangsu Province.
    Zhou L; Xu X; Antwi HA; Wang L
    Int J Equity Health; 2017 May; 16(1):89. PubMed ID: 28545456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Privatization of the medical market in socialist China: a historical approach.
    Liu G; Liu X; Meng Q
    Health Policy; 1994 Feb; 27(2):157-74. PubMed ID: 10133921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equity and efficiency of medical service systems at the provincial level of China's mainland: a comparative study from 2009 to 2014.
    Ding J; Hu X; Zhang X; Shang L; Yu M; Chen H
    BMC Public Health; 2018 Feb; 18(1):214. PubMed ID: 29402260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical policy in China.
    Sun Q; Santoro MA; Meng Q; Liu C; Eggleston K
    Health Aff (Millwood); 2008; 27(4):1042-50. PubMed ID: 18607039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-care reform: the issues and the role of donors.
    Foster S; Normand C; Sheaff R
    Lancet; 1994 Jul; 344(8916):175-7. PubMed ID: 7912773
    [No Abstract]   [Full Text] [Related]  

  • 39. Helping the decision maker effectively promote various experts' views into various optimal solutions to China's institutional problem of health care provider selection through the organization of a pilot health care provider research system.
    Tang L
    Health Res Policy Syst; 2013 Apr; 11():11. PubMed ID: 23557082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of government investment in primary healthcare institutions to promote equity during the three-year health reform program in China.
    Zhang X; Xiong Y; Ye J; Deng Z; Zhang X
    BMC Health Serv Res; 2013 Mar; 13():114. PubMed ID: 23530658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.